Articles

GABAergic signaling in alcohol use disorder and withdrawal: pathological involvement and therapeutic potential

• Ravinder Naik Dharavath
• Celeste Pina-Leblanc
• Victor M. Tang
• Matthew E. Sloan
• Yuliya S. Nikolova
• Peter Pangarov
• Anthony C. Ruocco
• Kevin Shield
• Daphne Voineskos
• Daniel M. Blumberger

Immune checkpoint inhibitors in first-line therapies of metastatic or early triple-negative breast cancer: a systematic review and network meta-analysis

in Cancer Endocrinology

• Xueyan Liang
• Xiaoyu Chen
• Huijuan Li
• Yan Li

Immunotherapy in Lung Cancer: Current Landscape and Future Directions

in Cancer Immunity and Immunotherapy

• Hirva Mamdani
• Sandro Matosevic
• Ahmed Bilal Khalid
• Gregory Durm
• Shadia I. Jalal

Combination of Ablation and Immunotherapy for Hepatocellular Carcinoma: Where We Are and Where to Go

in Cancer Immunity and Immunotherapy

• Kunpeng Wang
• Cong Wang
• Hao Jiang
• Yaqiong Zhang
• Weidong Lin
• Jinggang Mo
• Chong Jin

The Role of NcRNAs to Regulate Immune Checkpoints in Cancer

in Cancer Immunity and Immunotherapy

• Yicun Jiang
• Leilei Zhao
• Yiwen Wu
• Sijun Deng
• Pu Cao
• Xiaoyong Lei
• Xiaoyan Yang

Ibrexafungerp, a Novel Oral Triterpenoid Antifungal in Development: Overview of Antifungal Activity Against Candida glabrata

in Fungal Pathogenesis

• Ahmed Gamal
• Sherman Chu
• Thomas S. McCormick
• Katyna Borroto-Esoda
• David Angulo
• Mahmoud A. Ghannoum

Neoadjuvant immunotherapy plus chemotherapy for squamous cell carcinoma of the paranasal sinus: a case report

in Cancer Immunity and Immunotherapy

• Ying Sun
• Guanghui Yang
• Ruijie Sun
• Fangli Cao

Complete remission in a patient with sinonasal squamous cell carcinoma receiving neoadjuvant tislelizumab plus chemotherapy: a case report

in Cancer Immunity and Immunotherapy

• Fang Chen
• Hongzheng Zhang
• Yonghe Li
• Tingfeng Liang
• Tao Zhang

Comparative effectiveness of two first-line, ICI-based regimens for advanced HCC: a target trial emulation using an electronic medical record network

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

• Chihiro Shiraishi
• Miho Shigyou
• Ryuichi Inoue
• Toru Ogura
• Susumu Kaneshige
• Toshinobu Hayashi

Early life phenobarbital exposure dysregulates the hippocampal transcriptome

in Neuropharmacology

• Seán Quinlan
• Tahiyana Khan
• David McFall
• Carolina Campos-Rodriguez
• Patrick A. Forcelli

Breaking the cycle of malaria treatment failure

in Infectious Disease Epidemiology

• Maciej F. Boni

Mesenchymal Stem Cells in Gastric Cancer: Vicious but Hopeful

in Gastrointestinal Cancers

• Yuyi Li
• Xingwei Zhong
• Yunzhu Zhang
• Xinliang Lu

Pulmonary enteric adenocarcinoma with progression disease after second - line therapy: a case report

in Thoracic Oncology

• Ya Guo
• Bin Zhang
• Heng Zhang
• Yunbin Gao
• Haibo Zhao
• Pei Jiang
• Qing-Qing Yu

Case report: Tocilizumab for hypersensitivity reaction after oxaliplatin in a patient with NK/T-cell lymphoma

in Pharmacology of Anti-Cancer Drugs

• Juanyan Liao
• Ming Jiang

Targeting the plasticity of intestinal neutrophils: bidirectional regulation strategies by natural products

in Mucosal Immunity

• Ruotong Kang
• Anqi Sun
• Jiayin Yang
• Linyuan Chang
• Wenguang Sun
• Fushun Kou
• Yuan Cheng

Tislelizumab efficacy and safety compared to other anti–PD-1s: a network meta-analysis of first-line therapies for unresectable, locally advanced or metastatic esophageal squamous cell carcinoma

in Cancer Immunity and Immunotherapy

• Jaffer A. Ajani
• Elizabeth Smyth
• David Tougeron
• Hyun Ae Jung
• Wenxi Tang
• Jason Steenkamp
• Emily Prentiss
• JeanPierre Coaquira Castro
• Kirk Szafranski
• Lin Zhan